abcdefghijklmn
opqrstuvwxyz
Test Menu
Test Change Details
Allergy & Immunology
Cardiology & Coagulation
Dermatopathology
Endocrinology
Gastroenterology
Genetics
Hepatology
Infectious Disease
Microbiology
Nephrology
Neurology
Oncology
Pathology
Pediatrics
Rheumatology
Toxicology
Urology
Women's Health
3258SR: CEA w/Serial Reporting Print View
CEA IA  < 2.5  ng/mL 

PRIMARY
1 Serum 1 (0.5) mL   Room Temperature - 7 Day(s)/Frozen - 30 Day(s)/Refrigerated - 30 Day(s)  
ALTERNATE

Increased serum CEA levels have been detected in persons with primary colorectal cancer and in patients with other malignancies involving the gastrointestinal tract, breast, lung, ovarian, prostatic, liver, and pancreatic cancers. Elevated serum CEA levels have also been detected in patients with nonmalignant disease, especially patients who are older or who are smokers. CEA levels are not useful in screening the general population for undetected cancers. However, CEA levels provide important information about patient prognosis, recurrence of tumors after surgical removal, and effectiveness of therapy. See Carcinoembryonic Antigen (CEA) in the Hematology/Oncology chapter, Interpretive Information section.

Transport Room Temperature
Setup Schedule
Sunday-Saturday

Reported (Analytical Time)
Same day

CPT Code
82378

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Notes
Diagnostic code required for third party reimbursement. For Serial Graphic reporting, you must provide the patient's Social Security Number.






1996 - 2017 Quest Diagnostics Nichols Institute of Valencia
For test information, please call Client Services at 800-421-4449.

San Francisco Web Design & Database